U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07187830) titled 'Adipose Tissues and Liver Changes Associated Semaglutide in CKD' on Sept. 16.
Brief Summary: Obesity is considered a global pandemic and is associated with various diseases and metabolic complications, such as type 2 diabetes mellitus, high blood pressure, cholesterol disorders, cancer, cardiovascular disease, and kidney disease. Obesity can affect the kidneys in two main ways: indirectly, through mechanisms related to diabetes and/or high blood pressure, and directly, through complex proteins called "adipokines," which are produced by adipokines.
Many of these adipokines are secreted by adipokines under normal conditions, as they...